retatrutide clinical trial results 2024 2025 press release Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity Lilly's triple G agonist boasts
Pay in 4 interest-free payments of $7.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21

























